Effects of estradiol valerate and dienogest on quality of life and sexual function according to age.
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
The E2V/DNG pill improved general health and vitality scores in women aged 25-45, with varying effects on sexual function domains across age groups but no overall difference by age.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This is an observational study on 102 women aged 25-45 years to evaluate if the E2V/DNG pill has any impact on quality of life (QoL) and sexual function (FSF). Thirty-nine women were younger than 35 years (group A), and 63 women were 35 years old or older (group B). At baseline and after 6 months, patients received the Italian validated version of the Short Form-36 questionnaire and the Italian validated version of the Female Sexual Function Index questionnaire. Group A showed an overall higher perception in all QoL scores at baseline and after 6-months (p < 0.05). E2V/DNG treatment did not exert any significant effect on QoL perception in group A apart from an increase in the GH domain (general health). In group B we observed a significant improvement both in GH and in VT (vitality) scores. We found a significant reduction in "lubrication" after 6 months both in group A and B (p < 0.01) and a significant improvement in "satisfaction" and "pain" scores in group A and in "desire", "satisfaction" and "total" score in group B (p < 0.01). The E2V/DNG pill is associated with a significant improvement of GH and VT and with an improvement in FSF with no difference between age groups.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Preliminary Study on the Effect of Four-phasic Estradiol Valerate and Dienogest (E2V/DNG) Oral Contraceptive on the Quality of Sexual Life 2011
- Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest 2013
Cited by (4)
- Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study 2018
- Satisfaction of young women with estradiol valerate/dienogest in real clinical practice in Russia: results of prospective multicenter observational study Q-SWAN 2025
- Effects of Combined Oral Contraceptives on Women’s Sexual Function, Eje Cafetero, Colombia, 2016-2020 2022
- Overview of the therapeutic possibilities of combined oral contraceptive containing estradiol valerate and dienogest 2019
References (19)
- Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest via openalex
- Preliminary Study on the Effect of Four-phasic Estradiol Valerate and Dienogest (E2V/DNG) Oral Contraceptive on the Quality of Sexual Life via openalex
- doi:10.1016/0378-5122(82)90064-0 via openalex
- doi:10.1111/j.1743-6109.2012.03004.x via openalex
- doi:10.1136/bmj.323.7322.1192 via openalex
- doi:10.1111/j.1447-0756.2007.00581.x via openalex
- doi:10.1016/j.contraception.2011.08.004 via openalex
- W2231071522 via openalex
- doi:10.1007/s10508-007-9302-0 via openalex
- doi:10.1016/s0895-4356(98)00179-6 via openalex
- doi:10.1002/0471725250.scard via openalex
- doi:10.1080/09513590801925596 via openalex
- doi:10.1080/00926230590475206 via openalex
- doi:10.1080/009262300278597 via openalex
- doi:10.1111/j.1945-1474.2002.tb00463.x via openalex
- doi:10.3109/09513590.2013.848851 via openalex
- doi:10.2307/1271101 via openalex
- doi:10.1016/j.contraception.2004.06.010 via openalex
- doi:10.1016/s0895-4356(98)00107-3 via openalex
Cited by (4)
- Satisfaction of young women with estradiol valerate/dienogest in real clinical practice in Russia: results of prospective multicenter observational study Q-SWAN 2025
- Effects of Combined Oral Contraceptives on Women’s Sexual Function, Eje Cafetero, Colombia, 2016-2020 2022
- Overview of the therapeutic possibilities of combined oral contraceptive containing estradiol valerate and dienogest 2019
- Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study 2018
Source provenance
- openalex
- last seen: 2026-05-11T06:40:38.933960+00:00
License: CC0
· commercial use OK